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Heart Failure and a Normal Ejection Fraction
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Mathew S. Maurer, MD, Daniel Burkhoff, MD, PHD, Linda P. Fried, MD, MPH,
John Gottdiener, MD, FACC, Donald L. King, MD, Dalane W. Kitzman, MD, FACC
New York, New York
Objectives The purpose of this study was to evaluate left ventricular (LV) size and structure in elderly subjects with hyper-
tension (HTN) and heart failure who have a normal ejection fraction (HFNEF) in a large population-based sample.
Background The pathophysiology of HFNEF is incompletely understood but is generally attributed to LV diastolic dysfunction
with normal or reduced LV diastolic chamber size despite greater than normal filling pressures.
Methods In the Cardiovascular Health Study (n  5,888), demographic and clinical characteristics and ventricular struc-
ture and function were compared in healthy normal subjects (healthy; n  499), subjects with HTN but not heart
failure (HTN; n  2,184), and subjects with HTN and HFNEF (HFNEF; n  167).
Results Subjects with HFNEF were older, more obese, and more often African American than healthy and HTN subjects
and had a higher prevalence of diabetes, coronary heart disease, and anemia than HTN subjects. Serum creati-
nine and cystatin-C were increased in HFNEF subjects. Average LV diastolic dimension was significantly in-
creased in HFNEF subjects (5.2  0.8 cm) compared with healthy (4.8  0.6 cm) and HTN (4.9  0.6 cm) sub-
jects. As a result, average calculated stroke volume (89  25 ml vs. 78  20 ml and 80  20 ml) and cardiac
output (6.0  2.0 l/min vs. 4.8  1.3 l/min and 5.1  1.4 l/min) were increased in HFNEF compared with
healthy and HTN subjects, respectively.
Conclusions As a group, HFNEF subjects have increased LV diastolic diameter and increased calculated stroke volume. They
also have increased prevalence of multiple comorbidities, including anemia, renal dysfunction, and obesity, that
can cause volume overload. These data suggest that extracardiac factors, via volume overload, may contribute
to the pathophysiology of HFNEF in the elderly. (J Am Coll Cardiol 2007;49:972–81) © 2007 by the American
College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.10.061p
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Multiple population-based studies have shown
that among the elderly the majority with heart
failure have a normal ejection fraction (HF-
NEF) and a history of hypertension (1–3).
However, the pathophysiology of this disorder
is poorly understood. It is usually attributed
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ccepted October 24, 2006.rimarily to left ventricular (LV) diastolic dysfunction, and
as often been termed diastolic heart failure (4–7). In
iastolic heart failure, LV diastolic chamber size is usually
ormal or reduced despite greater than normal filling
See page 982
ressures (6,8–10). However, LV diastolic chamber size has
een reported in relatively modest numbers of patients with
ypertensive HFNEF. Further, reports have been contra-
ictory, with some indicating that LV volumes and cardiac
utput (CO) are indeed normal or reduced (1,7,11,12) and
thers indicating that LV volumes are increased (13–15),
uggestive of a volume overload state.
The CHS (Cardiovascular Health Study) is a National Heart,
ung, and Blood Institute-sponsored multicenter population-
ased longitudinal cohort study of cardiovascular disease risk in
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March 6, 2007:972–81 LV Size in HFNEF,888 people 65 years of age. In the CHS population a
ubstantial percentage of subjects had hypertension with or with-
ut heart failure and a normal ejection fraction (EF). Multiple
hysiologic measurements were performed, including echocardi-
graphy, by a standardized protocol (16). Thus, using CHS data,
t was possible to examine LV size and function, renal function,
nd other relevant covariates as well as comorbidities that might
ffect ventricular volume in a population-based cohort of elderly
ubjects, including not only a group of subjects with HFNEF but
lso an “active” control group with chronic hypertension (HTN)
ut no heart failure and a healthy control group, to gain insight
nto the pathophysiology of HFNEF.
ethods
tudy design and subjects. The overall design, objectives,
nd recruitment strategy of the CHS have been reported in
etail (17). The CHS was designed to assess cardiovascular
isease, cardiovascular disease outcomes, and risk factors
mong the elderly. Noninstitutionalized, independently liv-
ng, community-dwelling participants 65 years of age or
lder were recruited from 4 geographically dispersed field
enters: Forsysth County, North Carolina; Sacramento
ounty, California; Allegheny County, Pennsylvania; and
ashington County, Maryland. Persons were excluded from
he CHS if they were receiving active treatment for cancer,
ere wheelchair bound or institutionalized, or were unable to
articipate in the examination. Prevalent coronary artery dis-
ase, stroke, and heart failure were not exclusion criteria. The
riginal cohort (recruited in 1989 to 1990; n  5,201) and
hose enrolled when the study was expanded to include more
frican Americans (in 1992 to 1993; n  687) comprised
,888 study participants (2,495 men and 3,393 women). The
resent study consisted of an analysis of echocardiographic data
btained at the baseline visit for the original cohort and at 2
ears after the baseline visit for the second cohort.
tudy groups. Three groups of participants with normal EF
55%) were identified from the CHS study participants.
ealthy control subjects (n  499) were defined by a normal
F and the absence of prevalent or incident heart failure,
ignificant valvular dysfunction, transient ischemic attack,
troke, myocardial infarction, angina or claudication, history of
evascularization, HTN (defined by systolic blood pressure
140 mm Hg or diastolic 90 mm Hg or a reported history
f HTN and use of antihypertensive medications), or diabetes
defined according to the American Diabetes Association
riteria) and were not using beta-blockers, ACE inhibitors,
igitalis, warfarin, or any other prescription medications up to
he time of the first echocardiogram. Hypertensive participants
ithout heart failure (HTN; n  2,184) had a normal EF
ithout any prevalent heart failure up to the time of the
chocardiographic examination. Hypertensive participants
ith heart failure and normal EF (HFNEF; n 167) included
ubjects with hypertension and prevalent heart failure with a
ormal EF at the time of the echocardiographic examination,n the absence of significant aortic or mitral valvular disease. definition of clinical param-
ters. Details of the methods
sed to assess the presence of heart
ailure among participants in the
HS have been reported previ-
usly (18,19). In brief, an expert
anel adjudicated the index event
f heart failure by reviewing all
ertinent data on the hospitaliza-
ion or outpatient visit, including
istory, physical examination, re-
ort of chest radiography, and
edication usage. Self-report of a
hysician diagnosis of heart failure was confirmed by docu-
entation in the medical record of a constellation of symptoms
shortness of breath, fatigue, orthopnea, paroxysmal nocturnal
yspnea) and physical signs (edema, pulmonary rales, gallop
hythm, displaced LV apical impulse) or by supporting clinical
ndings, such as those from chest radiography. Diagnosis of
eart failure was confirmed also if, in addition to having a
revious physician diagnosis, the participant was receiving
edical therapy for heart failure (a current prescription of a
iuretic and digitalis or a vasodilator (nitroglycerin, hydral-
zine, or angiotensin-converting enzyme inhibitor). For the
resent study, any participant with at least 1 confirmed episode
f heart failure before or at the time of their initial echocar-
iogram was considered to be prevalent for heart failure.
omorbid conditions. Comorbid conditions were evalu-
ted based on patient status available up to the time of the
rst echocardiogram and therefore include both prevalence
nd incidence data. Anemia was defined according to the
orld Health Organization criteria as hemoglobin 12
g/dl in women and 13 mg/dl in men (20). Diabetes was
efined according to American Diabetes Association crite-
ia. Coronary heart disease was defined by the presence of
revious myocardial infarction, angina pectoris, bypass sur-
ery, or percutaneous coronary intervention. Renal function
as assessed by serum creatinine measured using the Kodak
ktachem 700 Analyzer (Eastman Kodak, Rochester, New
ork), a colorimetric method. Glomerular filtration rates
ere estimated from serum creatinine by standard formulas
21) and graded, as defined by national guidelines (22), as
ormal, mild, moderate, or severe failure. Cystatin-C, a
ovel serum measure of renal function, was measured from
amples collected at the 1992 to 1993 visit and stored at
70°C, using a BNII nephelometer (Dade Behring, Deerfield,
llinois) and a particle-enhanced immunonephelometric as-
ay (N Latex Cystatin-C, Dade Behring) (23).
chocardiographic assessments. Echocardiography meth-
ds in the CHS have been published previously (16). In
rief, M-mode 2-dimensional color Doppler and spectral
oppler standardized examinations with prespecified se-
uence, technique and priorities were performed at each
eld site with a Toshiba (Tustin, California) SSH-160A
ltrasound machine fitted with standard 2.5-MHz trans-
Abbreviations
and Acronyms
CHS  Cardiovascular
Health Study
CO  cardiac output
EF  ejection fraction
HFNEF  heart failure with
normal ejection fraction
HTN  hypertension
LV  left ventricle
SV  stroke volumeucers. Studies were recorded onto super-VHS videotapes
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LV Size in HFNEF March 6, 2007:972–81nd batch-mailed to the echocardiography reading center
here best images from each study were selected and
igitized. Measurements were obtained on a digital image
nalysis system (Nova Microsonics, Allendale, New Jersey).
Two dimensional guided M-mode measurements of sys-
olic and diastolic chamber dimensions and wall thickness
ere obtained according to the recommendations of the
merican Society of Echocardiography (24), and LV mass
as derived from the formula described by Devereux et al.
25,26). Valvular regurgitation and stenosis were assessed as
reviously described (16). Of the 2,850 subjects in this study,
,785 (63%) had M-mode echocardiographic data available for
nalysis of LV size and function and myocardial characteristics.
mong the groups, data for LV size were available in 343
ontrol (69%) subjects, 1,356 (62%) HTN subjects, and 86
51%) HFNEF subjects. The major reason for data unavail-
Demographic and Clinical Characteristics
Table 1 Demographic and Clinical Characte
Parameters Controls
n 499
Age (yrs) 71 5
Gender (% female) 57%
Race (%)
European American 93
African American 6.6
American Indian/Alaskan Native 0.2
Asian/Pacific Islander —
Other 0.2
Height (cm) 166 9
Weight (kg) 70 13
BSA (m2) 1.75 0.1
BMI (kg/m2) 25 4
Hemodynamics
Heart rate (beats/min) 63 11
Systolic blood pressure (mm Hg) 123 10
Diastolic (mm Hg) 68 8
Renal function
Serum creatinine (mg/dl) 1.0 0.2
Serum cystatin-C (mg/l) 1.0 0.2
Estimated GFR (ml/min) 63 16
Comorbidities (%)
Diabetes mellitus 0
Coronary heart disease 0
Angina 0
Myocardial infarction 0
PTCA 0
CABG 0
Obesity‡ 11
Anemia§ 7
Chronic renal disease
Failure (15 ml/min) 0
Severe (15–30 ml/min) 1
Moderate (30–60 ml/min) 48
Mild (60–90 ml/min) 46
None (90 ml/min) 5
*p  0.05 versus healthy control subjects; †p  0.05 versus HTN by e
continuous variables or chi-squared analysis for dichotomous variables
mg/dl in women and 13 mg/dl in men.ANOVA  analysis of variance; BSA  body surface area; CABG  coronary
failure with normal ejection fraction; HTN  hypertension; PTCA  percutanebility was an inadequate acoustic window such that echocar-
iographic quantitative measurements were not possible. A
maller number were unavailable owing to inadequate Doppler
racings or to atrial fibrillation or mitral or aortic regurgitation
hat could alter the Doppler parameters.
Left ventricular end-diastolic and -systolic volumes (EDV and
SV, respectively) were calculated from M-mode echocardio-
raphic dimensions by a previously validated technique (27):
EDV 4.5 (LV diastolic dimension)2 [1]
ESV 3.72 (LV systolic dimension)2 [2]
ecause this technique has been shown to be reliable only in
ymmetrically contracting ventricles with normal ejection frac-
ion, subjects with a regional wall motion abnormality were
s
HTN Without HF HTN With HFNEF
2,184 167
73 6* 76 7*†
63% 57%
77.8* 64.5*
21.6 33.1
0.1 1.2
0.1 —
0.3 1.2
164 9* 164 9
74 15* 73 17*
1.78 0.20* 1.77 0.20
27 5* 27 6*
65 11* 68 14*†
148 22* 147 25*
73 12* 71 13*
1.1 0.5* 1.2 0.5*†
1.1 0.4* 1.3 0.4*†
61 20 56 22*†
20* 30*†
20* 58*†
18* 51*†
8* 31*†
2* 5*†
3* 12*†
25* 29*
8 19*†
0.1* 4*†
3 4
47 53
41 32
8 6
OVA with Bonferroni post hoc correction for multiple comparisons of
ed by bodymass index (BMI)3 kg/m2; §defined by hemoglobin12ristic
9
ither AN
; ‡definartery bypass graft; GFR  glomerular filtration rate; HFNEF  heart
ous transluminal coronary angioplasty.
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March 6, 2007:972–81 LV Size in HFNEFxcluded from these calculations. From these volumes, stroke
olume (SV) was estimated as: EDV  ESV. Cardiac output
as calculated as: SV  heart rate.
Transmitral Doppler LV filling recordings were per-
ormed from the apical 4-chamber view and analyzed for
iastolic filling indexes, including peak E- and A-wave
elocities and their ratio.
tatistical analysis. Data are expressed as mean  standard
eviation. Chi-square test or analysis of variance was used for
nadjusted analyses of the associations among groups and
aseline variables. Differences in dichotomous variables were
lso corrected for multiple comparisons. Ventricular size was
ndexed to age, gender, body surface area, and race in the
ollowing manner. Measured LV internal diameter in diastole
LVIDd) was divided by LVIDPredicted (determined from the
arameter estimates of multivariate linear regression analyses)
nd multiplied by 100. These data were analyzed with the
olmogorov-Smirnov goodness-of-fit tests for normal distri-
ution, which confirmed a normal distribution of the data.
ifferences in continuous variables between the HFNEF and
ontrol participants were compared using analysis of variance
ith a Bonferroni correction for multiple comparisons. Be-
ause ventricular diameter is known to vary with age, gender,
nd body size (28,29), these were also compared between
roups with analysis of covariance with Bonferroni contrasts
sing age, gender, body size, and race as covariates. A p value
f  0.05 was considered to be significant. The SAS 9.0
rogram (SAS Institute, Cary, North Carolina) was used for all
nalyses.
esults
linical characteristics (Table 1). Subjects with HFNEF
ere older than either healthy normal control subjects or
ubjects with HTN alone. Compared with normal controls,
ubjects with HTN alone and subjects with HFNEF were
ore often African American and had higher body weights
nd body mass indexes. African Americans accounted for
6% of the overall CHS study population (924 of 5,888
ubjects) but were over-represented in the groups with
TN (22%, 472 of 2,184) and HFNEF (33%, 55 of 167).
he prevalence of several comorbid conditions, including
iabetes, coronary heart disease, anemia, and chronic renal
isease, was increased in subjects with HTN compared with
ealthy control subjects, and these were even more prevalent
n subjects with HFNEF.
Heart rate was increased in subjects with hypertension
ompared with control subjects and greatest in subjects with
FNEF. By definition, blood pressure was increased in
ubjects with HTN and HFNEF compared with controls
ut did not differ between HTN and HFNEF subjects.
V size and function. Of the 2,850 subjects in this study,
,785 (63%) had M-mode echocardiographic data available
or analysis of LV size and function and myocardial char-
cteristics (Table 2). Among the groups, data for LV size
as available in 343 (69%) control, 1,356 (62%) HTN, and
6 (51%) HFNEF subjects. aAverage LV systolic and diastolic dimensions did not
iffer between control subjects and those with HTN alone,
ut they were significantly larger in subjects with HFNEF.
ccordingly, average calculated end-diastolic and end-
ystolic volumes were increased in HFNEF compared with
he other groups (14% vs. 17%, respectively). Subjects with
FNEF demonstrated increased E-wave velocity compared
ith HTN and control subjects, and E/A ratios also were
ignificantly higher.
Both HTN and HFNEF subjects had LV hypertrophy with
ncreased posterior wall thickness and LV mass. In comparison
ith healthy normal control subjects, both HTN and HFNEF
roups had evidence of concentric remodeling (increased rela-
ive wall thickness and lower EDV:mass ratio), but neither
elative wall thickness nor the EDV:mass ratio differed be-
ween the HTN and HFNEF groups.
Functionally, fractional shortening and EF were slightly
igher in the HTN group. Compared with healthy normal
ontrol subjects and HTN subjects, calculated SV, CO, and
ardiac index were all increased in HFNEF. Notably,
stimated CO at rest was on average more than 1 l/min
reater in HFNEF subjects than in healthy control subjects
chocardiography
Table 2 Echocardiography
Parameters Control HTN Without HF HFNEF With HTN
LV size
LVIDd (cm) 4.8 0.6 4.9 0.6 5.1 0.8*†
LVIDd/BSA (cm/m2) 2.8 0.4 2.8 0.4 2.9 0.5†
LVIDs (cm) 2.8 0.5 2.7 0.6 3.0 0.7†
LVIDs/BSA (cm/m2) 1.6 0.3 1.6 0.3 1.7 0.4†
EDV (ml) 109 27 110 28 124 38*†
EDV/BSA (ml/m2) 63 14 62 14 69 22*†
ESV (ml) 30 12 29 12 35 16†
ESV/BSA (ml/m2) 18 6 17 6 20 10*†
Myocardial characteristics
PWT (cm) 0.8 0.1 0.9 0.2* 0.9 0.2*
LV mass (g) 134 37 153 48* 176 64*†
LV mass/BSA (g/m2) 78 20 87 24* 98 34*†
RWT (cm) 0.34 0.07 0.37 0.09* 0.36 0.11
EDV/LV mass (ml/g) 0.83 0.16 0.74 0.17* 0.75 0.22*
CESS (g/cm2) 57 21 60 24 63 26
LV function
Fractional shortening (%) 42 7 44 8* 42 7
Ejection fraction (%) 72 7 74 7* 72 7
Stroke volume (ml) 78 20 80 20 89 25*†
SV/BSA (m/m2) 45 11 46 11 50 14*†
Cardiac output (l/min) 4.8 1.3 5.1 1.4* 6.0 2.0*†
Cardiac index (l/min/m2) 2.8 0.8 2.9 0.8 3.4 1.2*†
Mitral Doppler flow
E velocity (cm/s) 70 15 72 19 79 27*†
A velocity (cm/s) 71 18 84 23* 81 31*
E/A ratio 1.0 0.3 0.9 0.5* 1.3 1.2*†
ata for LV size was available in 343 control, 1,356 HTN without HF, and 86 HFNEF subjects; *p
.05 versus healthy controls; †p 0.05 versus HTN by ANOVA with Bonferroni post hoc correction
or multiple comparisons.
CESS  circumferential end-systolic stress; EDV  end-diastolic volume; ESV  end-systolic
olume; LV  left ventricular; LVIDd  left ventricular internal dimension in diastole; LVIDs  left
entricular internal dimension in systole; PWT  posterior wall thickness; RWT  relative wall
hickness; other abbreviations as in Table 1.nd subjects with HTN alone.
(
i
a
a
c
s
u
i
d
H
w
r
t
d
g
a
m
p
s
m
m
r
s
t
c
w
s
m
c
h
c
s
C
a
t
i
f
e
s
c
E
m
c
g
t
s
a
g
c
h
i
n
o
u
u
D
T
c
a
e
m
976 Maurer et al. JACC Vol. 49, No. 9, 2007
LV Size in HFNEF March 6, 2007:972–81The distribution of LV end-diastolic chamber diameter
Fig. 1), indexed to body surface area by gender (Fig. 2) and
ndexed to body surface area, gender, and race as a percent-
ge of predicted indexed diameter (i.e., the LVID percent-
ge) (Fig. 3) for the 3 study groups are shown. In this elderly
ohort, age did not affect LV diastolic diameter. Chamber
ize indexed to known confounders was normally distrib-
ted in all groups, and all groups had subjects with LV
nternal dimensions that were below and above the pre-
icted values. However, compared with healthy control and
TN subjects, the distribution for the HFNEF subjects
as right shifted toward larger values and spanned a greater
ange. Similar rightward shifts were seen for the distribu-
ions of end-systolic volume, SV, and CO. The cumulative
istribution of LV diastolic diameter indexed for age,
ender, body size, and race (e.g., LVIDPredicted) (Fig. 3C)
lso shows a rightward shift in the curve, indicating that
any of the HFNEF patients’ LV size is increased com-
ared with healthy control and HTN subjects.
Several baseline demographic factors known to affect LV
ize differed among the study groups (Table 1). Therefore,
ultivariate linear regression analysis was performed to deter-
ine the relative contribution of age, gender, body size, and
ace to the differences in ventricular dimensions. The analyses
howed that LV end-diastolic dimension did not differ be-
ween HTN and control subjects but was, on average, in-
reased 3.5 mm (p  0.0001) in HFNEF subjects compared
ith healthy controls. In particular, the multiple linear regres-
ion analysis (Table 3) showed significant differences between
en and women and between European and African Ameri-
ans. In all subgroups, HFNEF subjects were older with a
igher prevalence of diabetes, coronary heart disease, and
hronic renal dysfunction than either control or HTN subjects,
Figure 1 Distribution of LVIDd
(Left) Histogram of the distribution of left ventricular internal dimensions in diasto
fraction with (HFNEF) and without (HTN) heart failure. (Right) The gaussian distribu
distributions with a shift in the HFNEF subjects toward larger volumes.imilar to the entire group of HFNEF subjects (Table 1). aardiac volumes were generally smaller in women than in men
nd, for both genders, average volumes were smaller in African
han in European Americans. Among various groups, includ-
ng men and women and European and African Americans we
ound that subjects with HFNEF had consistently larger
nd-diastolic dimensions than healthy control and HTN
ubjects. The same was true for ESV index, SV index, and
ardiac index (Fig. 4).
Although African Americans had smaller LV volumes than
uropean Americans (Table 3), formal statistical testing using
ultivariate regression analysis did not demonstrate a signifi-
ant interaction of race with the difference in heart size by
roup (control, HTN, or HFNEF) or gender. This suggests
hat in the current dataset, differences observed in ventricular
ize between groups are not significantly influenced by race.
In view of the increased prevalence of coronary artery disease
nd specifically history of myocardial infarction in the HFNEF
roup, we performed an analysis to determine if there was a
orrelation between myocardial infarction (MI) and increased
eart size. Incorporation of a history of MI into the multivar-
ate linear regression analysis of heart size yielded a statistically
onsignificant parameter estimate of 0.04 (p 0.43). The lack
f significance suggests that prior MI is not a major contrib-
ting factor to the increased heart size, but the study may be
nderpowered to detect such differences.
iscussion
hese data from the CHS indicate that compared with healthy
ontrol subjects or subjects with HTN alone, HFNEF subjects
re older with a higher prevalence of comorbid conditions,
specially chronic renal disease, anemia, and obesity, and are
ore often African American. The HFNEF subjects have, on
Dd) among control subjects and hypertensive subjects with a normal ejection
of LVIDd for the 3 cohorts (control, HTN, and HFNEF), demonstrating normalle (LVI
tionsverage, increased LV dimensions and calculated volumes
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March 6, 2007:972–81 LV Size in HFNEFompared with both normal control subjects and subjects with
TN but no heart failure before and after adjustment for
ender, body size, and race. These data have important
mplications for the understanding of the pathophysiology of
FNEF in the setting of HTN, as discussed subsequently.
entricular size in HFNEF. There have been 3 earlier
eports from the CHS database of studies dealing with the
opic of patients with HFNEF (1,30,31). There are slight
ariations in the characteristics of this population reported
mong the various studies. This is because of variations in
riteria for patient selection. Despite differences in selection
riteria and, therefore, differences in the group sample sizes
s well as variation in selection of cases based on incident or
revalent heart failure, 1 study in which chamber size was
eported demonstrated similar average increases in ventric-
lar size in the cohort with HFNEF compared with control
ubjects (31).
The distributions of echocardiographicmeasurements of
entricular diameter, even when indexed for known covari-
tes, are wide. Subjects from each of the 3 cohorts studied
ad ventricular dimensions that were both greater than and
ower than the age, gender, body size, and race predicted
Figure 2 Distribution of LVIDd Indexed to Body Surface
(Top) Histogram of the distribution of left ventricular internal dimensions in diasto
subjects with a normal ejection fraction with (HFNEF) and without (HTN) heart failu
the 3 groups (control, HTN, and HFNEF), demonstrating normal distributions with aeans (Fig. 1). These wide distributions are due to normal tiologic variation and to technical variation of the measure-
ent. As a result, when an individual subject’s LV diameter
s within the population normal range, one is precluded
rom determining whether it is increased, average, or de-
reased by a small amount for that particular individual.
owever, statistical analysis of a suitably large population
an distinguish groups. The data from CHS demonstrate
hat ventricular size for individuals with HFNEF can be
ncreased 10% to 15%, resulting in a shift in the distribution
f ventricular dimension in the HFNEF cohort. This shift
oes not preclude a significant proportion of the values for
V diastolic diameter in the HFNEF population remaining
ithin the normal or reduced range, even when adjusted for
ge, gender, body size, and race.
Increased ventricular diameter in the HFNEF group of
ubjects may also be explained by the presence of a few
ubjects with large ventricles not representative of the
emainder of the HFNEF group. To evaluate this possibil-
ty each of the 3 groups was tested and found to have normal
istribution of data rather than a bimodal distribution.
hus, the overall results are not merely due to a small
ubgroup of atypical patients with dilated ventricles within
Dd) indexed to body surface area (BSA) among control subjects and hypertensive
men (right) and women (left). (Bottom) The gaussian distributions of LVIDd for
in the HFNEF subjects toward larger volumes for men (right) and women (left).le (LVI
re for
shifthe HFNEF group. Additionally, the cumulative distribu-
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LV Size in HFNEF March 6, 2007:972–81ion of ventricular dimensions indexed to age, gender, body
ize, and race confirmed a rightward shift in the distribu-
ion, suggesting that many of the HFNEF patients had
ncreased LV size compared with healthy control and HTN
ubjects (Fig. 3C).
Increased ventricular size in the HFNEF group may be
aused by valvular regurgitation or subtle systolic dysfunc-
ion related to coronary artery disease. However, valvular
egurgitation cannot account for ventricular enlargement in
ur HFNEF subjects, because subjects with significant valve
Figure 3 Distribution of LVlDd Indexed
to Age, Gender, Body Size, and Race
(A) Histogram of the distribution of indexed left ventricular internal dimensions
in diastole (LVIDd), which was derived for each patient by dividing the mea-
sured LVIDd and dividing it by the LVIDPredicted from the multivariate linear
regression analyses multiplied by 100 among normal subjects and hyperten-
sive subjects with a normal ejection fraction with (HFNEF) and without (HTN)
heart failure. (B) The gaussian distributions of indexed LVIDd for the 3 groups
(control, HTN, and HFNEF), demonstrating normal distributions with a shift in
the HFNEF subjects toward larger volumes. (C) Cumulative distribution of con-
trol, HTN, and HFNEF participants by LVIDPredicted, which shows a rightward
shift in the curve, indicating that for a majority of the HFNEF cohort, ventricular
size is increased a small but significant amount compared with HTN and
healthy control subjects.egurgitation were excluded. Although subtle systolic dys- cunction was not evident based on the presence of a normal
F in all groups, previous data in an animal model have
emonstrated that a small amount of ischemic myocardial
njury can lead to neurohormonal activation with intravas-
ular volume expansion and elevation of LV end-diastolic
ressure in the absence of reductions in maximal dP/dt or
F (32). However, although the HFNEF cohort had a
igher prevalence of coronary artery disease (specifically
yocardial infarction), statistical analysis demonstrated that
his did not account for the observed difference in ventric-
lar diameter in this dataset.
ndexing heart size. Normalizing indices of ventricular
tructure and function for covariates including age, gender,
nd body size permits appropriate comparisons (28,29,33)
nd has been recommended (24) but infrequently used. The
resent analysis accounted for age, gender, body size, and
ace in the evaluation of heart size and function and
emonstrated that statistically significant increases in ven-
ricular size without indexing were magnified with indexing.
his is important when studying HFNEF, because of the
isproportionate representation of African Americans and
mall elderly women compared with the control groups.
In the present dataset, there was no significant association
f age with LV dimensions, possibly in part owing to the
arrow age range of the population, which is a fundamental
esign characteristic of the CHS. Although earlier literature
as emphasized that heart size varies with race (34–36), the
agnitude of this effect in relation to other demographic
eatures has not, to our knowledge, been evaluated or
mphasized. The results of multivariate analysis in the CHS
ormal control subjects suggest that race exerts as potent an
nfluence (if not a greater influence) on heart size as gender.
owever, to our knowledge, none of the previous echocar-
iographic studies that have characterized ventricular size
nd geometry in subjects with HFNEF controlled for race
n the analyses of heart structure and function. This is
articularly noteworthy, because many of these studies
ad a disproportionate representation of African Amer-
cans (7,10,12) compared with the respective control pop-
lation. Although the results of multivariate regression
nalysis did not demonstrate a significant interaction of the
rimary results by race, because of the small number of
frican American subjects with HFNEF with evaluable
chocardiographic data in the present dataset there is
elatively low statistical power to detect such differences.
urther study with larger datasets will be needed to ade-
uately address the impact of race on the increased LV size
bserved in the HFNEF cohort.
ncreased intravascular volume in HFNEF. The pres-
nce of increased end-diastolic dimension and, therefore,
DV, SV, and CO in the HFNEF subjects suggests that
ntravascular volume overload plays a role in the pathophys-
ology of HFNEF in some, if not many, patients. The CHS
opulation with HTN and HFNEF exhibited a high
revalence of comorbid conditions which may contribute to
uid retention and subsequently a high output state. Ex-
luding intracardiac shunts, all other high cardiac output
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March 6, 2007:972–81 LV Size in HFNEFtates involve extracardiac mechanisms (37). Specifically,
enal dysfunction (38), anemia (39), and obesity (40) were
ll more common individually and occurred more frequently
n combination in the HFNEF subjects than in control or
TN subjects and are each known to lead to fluid retention.
ndeed, 1 study found in hypertensive predominantly elderly
omen with HFNEF that total plasma volume was in-
reased from normal despite the use of high-dose diuretics
14). Thus, the CHS data lead to the hypothesis that
Figure 4 EDVI, SVI, and CI by Gender and Race in the Cohorts
Calculated end-diastolic volume index (EDVI), stroke volume index (SVI), and cardia
tion fraction with (HFNEF) and without (HTN) heart failure by gender and race (Euro
volumes and cardiac output were larger in HFNEF subjects than in control and HTN
Multivariate Analysis of Determinantsof Left Ventricular Internal Dime sion in Diastol
Table 3 Multivariate Analysis of Determinanof Left Ventricular Internal Dimensio
Covariates Parameter
Age (per yr) 0.00
Gender (female vs. male) 0.10
Body surface area (per m2) 1.18
Race (African vs. European American) 0.29
Group
HFNEF vs. control 0.35
HFNEF vs. HTN 0.21
HTN vs. control 0.10
Results of multivariate linear regression analysis delineating the effe
ventricular dimension in diastole on the Cardiovascular Health Study.
CI  confidence interval; other abbreviations as in Table 1.xtracardiac factors resulting in increased intravascular vol-
me may contribute importantly to the pathophysiology of
FNEF. Other mechanisms resulting inperipheral veno-
onstriction and central shift of blood volume could also
lay a role (41,42). However, the present study did not
ddress these mechanisms.
ignificance of LV hypertrophy. The presence of hyper-
rophy is usually observed in patients with HFNEF (2,3,43).
eft ventricular wall thickness, mass, and relative wall
ied
x (CI) in healthy control subjects and hypertensive subjects with a normal ejec-
Whites] and African Americans). In all groups, average calculated left ventricular
cts.
Diastole
tes 95% CI of the Estimates p Value
0.00714 to 0.00491 0.7176
0.18710 to 0.03040 0.0066
0.98627 to 1.38649 0.0001
0.38076 to 0.21426 0.0001
0.18609 to 0.53385 0.0001
0.07949 to 0.35772 0.0021
0.02035 to 0.18061 0.0140
ge, gender, body size, race, and group (control, HTN, HFNEF) on leftStud
c inde
pean [
subjee
ts
n in
Estima
111
875
638
751
997
861
048
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LV Size in HFNEF March 6, 2007:972–81hickness were increased and EDV/mass ratios were de-
reased in HFNEF, indicative of concentric hypertrophic
V remodeling. However, similar changes were found in
he HTN group, and, as a result, indices of ventricular
ypertrophic remodeling including relative wall thickness
nd volume/mass ratio did not differ between HFNEF and
TN subjects. Furthermore, the correlations between LV
olume and mass were very similar between HTN subjects
r 0.59; p 0.0001) and HFNEF subjects (r 0.56; p
.0001). Thus, the relationship between the degree of
ypertrophy and the degree of chamber dilation did not
iffer based on the presence of heart failure. This finding
uggests that LV hypertrophic remodeling may not neces-
arily be a primary pathophysiologic mechanism in patients
ith HFNEF. In many patients, increased mass may simply
eflect ventricular dilation with a concomitant increase in
yocardial volume, to maintain a normal wall stress, which
as similar in all groups (Table 2).
Normal values of fractional shortening are considered to
e in the range of 27% to 50% (24). The mean fractional
hortening was on the higher side of normal in all cohorts of
he present study. This is consistent with earlier reports of
he CHS (1,31) suggesting that patients with HFNEF do
ot have a significant impairment in systolic properties (44).
he relatively high values for the fractional shortening also
re concordant with other data suggesting that endocardial
hortening is increased in the elderly and subjects with LV
ypertrophy (45,46).
tudy limitations. The present study consisted of an anal-
sis of echocardiographic data obtained at the baseline visit
or the original cohort and 2 years after the baseline visit for
he second cohort, which were read by 2 different core labs.
owever, echocardiographic examinations were performed
n the same ultrasound machines, and the cardiac structures
nd functions that were measured were the same on both
xaminations. Comparison of the processing of a subset of
aseline tapes at the University of California, Irvine, Read-
ng Center and the Georgetown University Reading Center
evealed no systematic differences in processing or interpre-
ation of the echocardiograms. Additionally, none of the
resent conclusions were altered when the echocardio-
raphic data were examined separately by reading center.
The patient population studied is subject to both participa-
ion and survivor bias and may not be representative of the
haracteristics of patients initially presenting with HFNEF.
ndeed, the duration of heart failure before the performance
f the initial echocardiogram may be an important factor
nfluencing LV size. Unfortunately, such data are not
vailable in the CHS database and therefore could not be
ontrolled for in the present analyses. Additionally, al-
hough a majority (63%) of participants in CHS had
chocardiographic measures of LV size, missing data could
onfound our results. Among the groups, data for LV size
ere available in 343 (69%) control, 1,356 (62%) HTN, and
6 (51%) HFNEF subjects. Participants with echocardio-
raphic dimension measures were younger with smaller
ody size and less obesity and had less comorbid conditions.his is typical of population-based studies. However, across
he groups studied, there were no systematic differences
etween those who had LV size measured versus those who
id not.
The present study did not directly measure LV volumes
ut rather used a previously validated technique to estimate
entricular volumes from echocardiographic diameter (27).
his technique has been shown to be reliable in symmetri-
ally contracting ventricles with normal EF, as was the case
n the subjects studied. Although the EF derived from these
ata are higher than some other techniques, the volumetric
ata are similar to those derived from a population of elderly
ubjects with HFNEF studied with 3-dimensional echocar-
iography (14), and the ventricular volumes and CO ob-
ained in the normal control subjects are nearly identical to
ther values reported in the literature using cardiac magnetic
esonance imaging (28).
Another limitation of this and most studies of HFNEF is
hat all measurements were made at rest. Patients with
FNEF typically have chronic exercise intolerance and are
rone to bouts of acute pulmonary edema-limited cardio-
ulmonary and vascular reserve. Therefore, it is possible that
haracterization of ventricular properties identified at rest,
s in the present study, may not apply to conditions when
xercise or other hemodynamic stress is present.
onclusions
articipants in the population-based CHS with HTN and
FNEF had, on average, increased ventricular dimensions
nd therefore increased calculated volumes and CO com-
ared with healthy control subjects and participants with
TN without heart failure. Furthermore, they had no
reater concentric hypertrophic remodeling than hyperten-
ive participants without heart failure, and they had consid-
rably more frequent comorbidities, particularly ones that
ay cause volume overload, such as renal dysfunction and
nemia. These data suggest that groups exist within the
ypertensive HFNEF population and that volume overload
tates may contribute to the pathophysiology of this impor-
ant syndrome.
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